Department of Error

Yu L-M, Bafadhel M, Dorward J, et al. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet 2021; 398: 843–55—In this Article, in figure 1, “primary analysis” was corrected to “secondary analysis” in reference to the all participants population. In figure 2, the key was incorrect and has now been amended. In figure 3B, a typing error has been corrected in the p value for duration of illness. These corrections have been made to the online version as of Aug 18, 2021, and the printed version is correct.